Table 3 Effects of palmitic acid on blood parameters in Mus musculus.

From: In silico and in vivo assessment of the immunostimulatory activity of palmitic acid derived from Vernonia amygdalina

Groups

Doses (mg/kg)

PCV (%)

Hb (g/dl)

RBC (× 106 uL)

WBC (× 103 ul)

PLATELET

LYM (%)

NEUT (%)

MON (%)

EOS (%)

Palmitic acid

2

49 ± 4.0

15.85 ± 1.25

6.79 ± 1.23

4600 ± 666

88,000 ± 8083

73 ± 2.00

24 ± 2.00

1.5 ± 1.50

3.0 ± 0.50

Palmitic acid

5

48 ± 1.5

15.50 ± 0.60

7.88 ± 0.39

3433 ± 88

80,000 ± 16,042

74 ± 0.88

24 ± 0.50

2.0 ± 0.33

1.0 ± 0.00

Palmitic acid

10

47 ± 3.0

15.05 ± 1.35

7.44 ± 0.66

4483 ± 617

79,333 ± 8762

72 ± 1.45

27 ± 1.00

1.0 ± 0.00

2.0 ± 0.33

CONTROL

–

48 ± 1.8

15.90 ± 0.10

8.06 ± 0.32

3467 ± 188

92,250 ± 7663

72 ± 0.82

26 ± 0.33

1.0 ± 0.00

2.0 ± 0.29

CPE

50

50 ± 1.2

16.00 ± 0.38

7.43 ± 0.65

3825 ± 188

56,000 ± 4000

71 ± 2.85

22 ± 0.67*

1.7 ± 0.33

1.0 ± 0.00

Levamisole

50

41 ± 3.0

13.25 ± 0.95

6.85 ± 0.42

3625 ± 375

94,000 ± 14,000

65 ± 0.50

32 ± 1.50*

2.0 ± 1.00

1.5 ± 0.50

  1. CPE, Cyclophosphamide; PCV, Packed Cell Volume; Hb, Haemoglobin;RBC, Red Blood Cell Count; WBC, White Blood Cell Count; LYM, Lymphocyte; NEUT, Neutrophils; MON, Monocytes; EOS, Eosinophils.
  2. *Indicates a significant difference at a 95% confidence level compared with the control group.
  3. Data are expressed as Mean ± SEM.
Back to article page